What is Global Orally Dissolving Tablets (ODT) Excipient Market?
The Global Orally Dissolving Tablets (ODT) Excipient Market is a fascinating and complex field that is gaining increasing attention in the pharmaceutical industry. These excipients are the inactive substances that are used alongside the active pharmaceutical ingredients in a drug formulation. They play a crucial role in the manufacturing process, helping to enhance the bioavailability, stability, and functionality of the drugs. The ODT excipients are specifically designed for orally dissolving tablets, which are a unique form of medication that dissolves in the mouth, rather than being swallowed whole. This makes them particularly useful for patients who have difficulty swallowing, such as the elderly or children. The global market for these excipients is vast and varied, encompassing a range of different substances, each with their own unique properties and applications.
Binders, Glidents, Diluents, Disintegrants, Sweeteners, Others in the Global Orally Dissolving Tablets (ODT) Excipient Market:
Binders, Glidents, Diluents, Disintegrants, Sweeteners, and others are all key components of the Global Orally Dissolving Tablets (ODT) Excipient Market. Binders are used to hold the ingredients of a tablet together, ensuring that it maintains its shape and integrity. Glidents, on the other hand, are used to improve the flow of the tablet ingredients during the manufacturing process, preventing them from sticking together. Diluents are used to increase the bulk of a tablet, making it easier to handle and consume. Disintegrants are crucial for ensuring that the tablet breaks down properly in the body, releasing the active ingredients. Sweeteners are often added to make the tablets more palatable, particularly for children or those who find the taste of medication off-putting. Other excipients can include colorants, flavorings, and preservatives, all of which can enhance the overall appeal and effectiveness of the tablets. Each of these excipients plays a vital role in the formulation of orally dissolving tablets, contributing to their growing popularity in the pharmaceutical industry.
Anti-Psychotics Drug, Anti-Epileptics Drug, Others in the Global Orally Dissolving Tablets (ODT) Excipient Market:
The Global Orally Dissolving Tablets (ODT) Excipient Market has a wide range of applications, particularly in the treatment of psychiatric and neurological conditions. Anti-psychotics drugs, for example, are often formulated as orally dissolving tablets, making them easier to administer and more acceptable to patients. These drugs are used to treat a range of conditions, including schizophrenia, bipolar disorder, and major depressive disorder. Similarly, anti-epileptics drugs are also commonly formulated as ODTs. These drugs are used to control seizures in patients with epilepsy, a neurological disorder that affects millions of people worldwide. The use of ODT excipients in these drugs can enhance their effectiveness, improving patient compliance and outcomes. Other applications of ODT excipients can include pain relief, allergy medications, and treatments for gastrointestinal disorders, among others. The versatility and effectiveness of these excipients make them a valuable tool in the development of new and improved pharmaceutical products.
Global Orally Dissolving Tablets (ODT) Excipient Market Outlook:
The future of the Global Orally Dissolving Tablets (ODT) Excipient Market looks promising, with significant growth expected in the coming years. In 2022, the market was valued at a substantial US$ 16650 million. This figure is projected to increase to an impressive US$ 21290 million by 2029, representing a compound annual growth rate (CAGR) of 3.5% during the forecast period from 2023 to 2029. This growth is likely to be driven by a number of factors, including advances in pharmaceutical technology, increasing demand for more convenient and palatable medication options, and the growing prevalence of conditions that can benefit from ODT formulations. However, it's important to note that these projections are based on current market trends and conditions, and actual future growth may vary depending on a range of factors.
| Report Metric | Details |
| Report Name | Orally Dissolving Tablets (ODT) Excipient Market |
| Accounted market size in 2023 | US$ 17320 million |
| Forecasted market size in 2029 | US$ 21290 million |
| CAGR | 3.5 |
| Base Year | 2023 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| Production by Region |
|
| Sales by Region |
|
| By Company | BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, McePharma (Vivesa holding), Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
